Stay updated on CDX-0159 Phase 1 Clinical Trial
Sign up to get notified when there's something new on the CDX-0159 Phase 1 Clinical Trial page.

Latest updates to the CDX-0159 Phase 1 Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now presents the ClinicalTrials.gov record for the Phase 1 CDX-0159 study, including its purpose, participant criteria, treatment arms, safety outcome, and Kansas study location. It also shows the study as completed and provides its enrollment and record dates.SummaryDifference36%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check26 days agoChange DetectedA notice banner announces an NIH website transition and says “Super Intelligence” (SI) is replacing “Artificial Intelligence” (AI) in some NIH content.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a footer that includes 'Revision: v3.7.0', indicating the page is not accessible.SummaryDifference16%

Stay in the know with updates to CDX-0159 Phase 1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CDX-0159 Phase 1 Clinical Trial page.